Furthermore, in our validation cohort, NUDT10 expression was significantly associated with T stage (OR = 3.886, T4 vs. T1+ T2+ T3), lymph node metastasis (OR = 5.133, yes vs. no), and TNM stage (OR = 19, stage III vs. stage I + II). Here, NUDT10 is linked to metastatic malignant neoplasm in the lymph nodes.